Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -1.84%273.57B | 4.39%1.15T | 6.08%278.7B | 4.08%1.11T | 3.19%272.49B | 2.28%286.96B | 4.78%283.31B | 6.31%262.73B | 4.84%1.06T | 8.61%264.07B |
| Cost of revenue | -1.59%193.58B | 4.73%814.97B | 5.49%196.71B | 3.02%778.15B | 0.38%192.8B | 0.29%201.81B | 4.88%197.07B | 7.08%186.47B | 9.50%755.35B | 10.91%192.08B |
| Gross profit | -2.44%79.99B | 3.59%339.1B | 7.51%81.99B | 6.70%327.35B | 10.69%79.69B | 7.33%85.15B | 4.55%86.24B | 4.49%76.26B | -5.09%306.8B | 2.92%72B |
| Operating expense | 1.22%62.24B | 4.68%254.4B | 8.33%61.49B | 5.04%243.02B | 6.16%65.08B | 3.63%59.88B | 6.90%61.3B | 3.32%56.77B | 0.45%231.37B | 9.39%61.3B |
| Operating profit | -13.41%17.75B | 0.45%84.7B | 5.13%20.5B | 11.78%84.32B | 36.62%14.61B | 17.27%25.27B | -0.81%24.95B | 8.06%19.5B | -18.82%75.43B | -23.13%10.69B |
| Net non-operating interest income (expenses) | 154.55%84M | 181.82%341M | -8.33%33M | 268.06%121M | 109.52%44M | 350.00%40M | 108.33%1M | 155.38%36M | 69.87%-72M | 161.76%21M |
| Non-operating interest income | 73.87%193M | 48.16%723M | -14.62%111M | 25.13%488M | -4.07%118M | 27.18%131M | 1.87%109M | 128.07%130M | 49.43%390M | 51.85%123M |
| Non-operating interest expense | 39.74%109M | 4.09%382M | -17.02%78M | -20.56%367M | -27.45%74M | -23.53%91M | -9.24%108M | -22.95%94M | -7.60%462M | -11.30%102M |
| Net investment income | 18.26%1.02B | 0.19%1.62B | 0.35%860M | -28.53%1.61B | -26.26%292M | -58.38%447M | -71.67%17M | 17.88%857M | 29.42%2.26B | 189.05%396M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | -84.48%4.49B | 1,509.39%3.43B | 259.13%28.92B | 233.34%25.83B | -1.82%54M | 1,033.73%2.82B | 213M | 119.04%8.05B | 7.75B |
| Income from associates and other participating interests | 18.25%-721M | 48.30%-4.47B | 15.19%-882M | -295.33%-8.64B | -134.28%-6.91B | -257.04%-212M | -170.01%-481M | -1,662.71%-1.04B | -241.03%-2.19B | -187.99%-2.95B |
| Special income (charges) | 157.21%1.15B | 76.94%-4.02B | -162.82%-2.01B | -232.07%-17.43B | -284.38%-20.06B | 157.57%1.05B | -169.27%-1.62B | -32.45%3.2B | -57.14%13.2B | -61.14%10.88B |
| Less:Other special charges | -157.21%-1.15B | 101.89%3.85B | 162.82%2.01B | 114.17%1.91B | 140.74%4.54B | -157.57%-1.05B | 169.27%1.62B | 32.45%-3.2B | 56.31%-13.46B | 60.22%-11.14B |
| Less:Write off | ---- | -98.89%172M | ---- | 5,940.47%15.52B | ---- | ---- | ---- | ---- | --257M | ---- |
| Other non-operating income (expenses) | -159.67%-145M | 87.30%-177M | 278.68%243M | -9.51%-1.39B | 14.47%-325M | -144.16%-669M | 31.61%-264M | 41.63%-136M | 36.13%-1.27B | 65.17%-380M |
| Income before tax | -13.68%19.14B | -5.74%82.48B | -2.04%22.17B | -8.28%87.51B | -48.97%13.48B | 25.50%25.98B | 1.11%25.42B | -2.28%22.63B | -25.72%95.41B | -39.39%26.41B |
| Income tax | 7.52%8.35B | -15.97%28.4B | -23.39%7.77B | 41.32%33.79B | 82.63%8.17B | 33.08%7.97B | 16.52%7.51B | 44.82%10.14B | -33.70%23.91B | -64.92%4.47B |
| Net income | -25.12%10.78B | 0.69%54.09B | 15.30%14.4B | -24.87%53.72B | -75.79%5.31B | 22.42%18B | -4.21%17.91B | -22.69%12.49B | -22.61%71.5B | -28.84%21.94B |
| Net income continuous operations | -25.12%10.78B | 0.69%54.09B | 15.29%14.4B | -24.87%53.72B | -75.79%5.31B | 22.42%18B | -4.21%17.91B | -22.69%12.49B | -22.61%71.5B | -28.84%21.94B |
| Noncontrolling interests | 52.67%687M | 8.06%3.29B | -49.78%450M | 46.65%3.04B | -104.90%-418M | 21.01%979M | 19.11%1.58B | 544.60%896M | -57.61%2.07B | 58.02%-204M |
| Net income attributable to the company | -27.63%10.1B | 0.25%50.8B | 20.32%13.95B | -27.01%50.68B | -74.12%5.73B | 22.51%17.03B | -6.00%16.33B | -27.61%11.59B | -20.66%69.42B | -29.29%22.14B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -27.63%10.1B | 0.25%50.8B | 20.32%13.95B | -27.01%50.68B | -74.12%5.73B | 22.51%17.03B | -6.00%16.33B | -27.61%11.59B | -20.66%69.42B | -29.29%22.14B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -25.80%37.27 | 2.44%186.08 | 20.77%50.23 | -26.58%181.64 | -74.13%20.51 | 22.98%61 | -5.09%58.54 | -26.87%41.59 | -18.52%247.39 | -28.70%79.27 |
| Diluted earnings per share | -25.80%37.27 | 2.44%186.08 | 20.77%50.23 | -26.58%181.64 | -74.13%20.51 | 22.98%60.998 | -5.09%58.54 | -26.87%41.59 | -18.52%247.39 | -28.70%79.27 |
| Dividend per share | 0 | 5.26%100 | 0 | 5.56%95 | 0.00%47.5 | 0 | 11.76%47.5 | 0 | 5.88%90 | 5.56%47.5 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |